chloramphenicol has been researched along with Cystic Fibrosis in 32 studies
Amphenicol: Chloramphenicol and its derivatives.
Cystic Fibrosis: An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of exocrine pancreatic function on the pharmacokinetics of the choramphenicol oral capsule (CAP-base), chloramphenicol palmitate oral liquid (CAP-P), and chloramphenicol succinate intravenous (CAP-S) formulations was evaluated in 10 patients, aged 16-30 yr, with cystic fibrosis." | 7.67 | The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis. ( Aronoff, SC; Blumer, JL; Dickinson, CJ; Reed, MD; Stern, RC; Yamashita, TS, 1988) |
| " In the present study, the in vitro bactericidal activities of meropenem, either alone or in combination with colistin, levofloxacin, or chloramphenicol, were assessed using A." | 5.56 | Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis. ( Damar-Çelik, D; Nørskov-Lauritsen, N; Özbek-Çelik, B, 2020) |
| "Children with cystic fibrosis are commonly colonized with multi-resistant bacteria." | 5.46 | Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic Fibrosis. ( Abaji, R; Autmizguine, J; Goyer, I; Iseppon, M; Krajinovic, M; Thibault, C, 2017) |
| "The effect of exocrine pancreatic function on the pharmacokinetics of the choramphenicol oral capsule (CAP-base), chloramphenicol palmitate oral liquid (CAP-P), and chloramphenicol succinate intravenous (CAP-S) formulations was evaluated in 10 patients, aged 16-30 yr, with cystic fibrosis." | 3.67 | The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis. ( Aronoff, SC; Blumer, JL; Dickinson, CJ; Reed, MD; Stern, RC; Yamashita, TS, 1988) |
| "Three patients with cystic fibrosis of the pancreas initially were seen because of optic neuropathy caused by a toxic reaction to chloramphenicol." | 3.66 | Chloramphenicol optic neuropathy. ( Godel, V; Lazar, M; Nemet, P, 1980) |
| " In the present study, the in vitro bactericidal activities of meropenem, either alone or in combination with colistin, levofloxacin, or chloramphenicol, were assessed using A." | 1.56 | Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis. ( Damar-Çelik, D; Nørskov-Lauritsen, N; Özbek-Çelik, B, 2020) |
| "Children with cystic fibrosis are commonly colonized with multi-resistant bacteria." | 1.46 | Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic Fibrosis. ( Abaji, R; Autmizguine, J; Goyer, I; Iseppon, M; Krajinovic, M; Thibault, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (78.13) | 18.7374 |
| 1990's | 1 (3.13) | 18.2507 |
| 2000's | 2 (6.25) | 29.6817 |
| 2010's | 3 (9.38) | 24.3611 |
| 2020's | 1 (3.13) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, J | 1 |
| Chen, Y | 1 |
| Tabibi, S | 1 |
| Alba, L | 1 |
| Garber, E | 1 |
| Saiman, L | 1 |
| Mandsberg, LF | 1 |
| Ciofu, O | 1 |
| Kirkby, N | 1 |
| Christiansen, LE | 1 |
| Poulsen, HE | 1 |
| Høiby, N | 1 |
| Damar-Çelik, D | 1 |
| Nørskov-Lauritsen, N | 1 |
| Özbek-Çelik, B | 1 |
| Antonelli, A | 1 |
| D'Andrea, MM | 1 |
| Brenciani, A | 1 |
| Galeotti, CL | 1 |
| Morroni, G | 1 |
| Pollini, S | 1 |
| Varaldo, PE | 1 |
| Rossolini, GM | 1 |
| Long, SS | 1 |
| Goyer, I | 1 |
| Iseppon, M | 1 |
| Thibault, C | 1 |
| Abaji, R | 1 |
| Krajinovic, M | 1 |
| Autmizguine, J | 1 |
| LLOYD, AV | 1 |
| GRIMES, G | 1 |
| KHAW, KT | 2 |
| SHWACHMAN, H | 3 |
| LIETMAN, PS | 1 |
| DISANTAGNESE, PA | 1 |
| WONG, V | 1 |
| KEITH, CG | 2 |
| WONG, VG | 1 |
| COLLINS, E | 1 |
| STEIN, AA | 1 |
| MANLAPAS, FC | 1 |
| SOIKE, K | 1 |
| OPALKA, E | 1 |
| PATTERSON, P | 1 |
| Cocke, JG | 2 |
| Gurry, DL | 1 |
| Richardson, CJ | 1 |
| Huang, NN | 2 |
| Schidlow, DV | 1 |
| Palmer, JJ | 1 |
| Godel, V | 1 |
| Nemet, P | 1 |
| Lazar, M | 1 |
| Fowler, CE | 1 |
| Soothill, JS | 1 |
| Oakes, L | 1 |
| Geller, A | 1 |
| Gilles, F | 1 |
| Kapp, JP | 1 |
| Arora, B | 1 |
| Sibinga, MS | 1 |
| Dickinson, CJ | 1 |
| Reed, MD | 1 |
| Stern, RC | 1 |
| Aronoff, SC | 1 |
| Yamashita, TS | 1 |
| Blumer, JL | 1 |
| Spaide, RF | 1 |
| Diamond, G | 1 |
| D'Amico, RA | 1 |
| Gaerlan, PF | 1 |
| Bisberg, DS | 1 |
| Wright, GL | 1 |
| Harper, J | 1 |
| Zegarelli, EV | 1 |
| Kutscher, AH | 1 |
| Denning, CR | 1 |
| Ragosta, JM | 1 |
| Muschel, LH | 1 |
| Ahl, LA | 1 |
| Fisher, MW | 1 |
| Johansen, PG | 1 |
| Vichi, GF | 1 |
| Calandi, C | 1 |
| Lieberman, TW | 1 |
| Brown, RE | 1 |
| Geppert, LJ | 1 |
| Nielsen, EL | 1 |
| De Haller, J | 1 |
| Young, WF | 1 |
| Redmond, A | 1 |
| Hermier, M | 1 |
| Gilly, R | 1 |
| Chevallier, G | 1 |
| Harley, RD | 1 |
| Promadhattavedi, V | 1 |
| Sproul, A | 1 |
2 reviews available for chloramphenicol and Cystic Fibrosis
| Article | Year |
|---|---|
Antibiotics in pediatric respiratory diseases.
Topics: Aminoglycosides; Anti-Bacterial Agents; Cephalosporins; Child; Chloramphenicol; Cystic Fibrosis; Emp | 1980 |
Ocular effects of prolonged systemic drug administration. (Corticosteroids, chloramphenicol and anovulatory agents).
Topics: Animals; Arthritis, Rheumatoid; Cataract; Chloramphenicol; Contraceptives, Oral; Cystic Fibrosis; Ey | 1968 |
1 trial available for chloramphenicol and Cystic Fibrosis
| Article | Year |
|---|---|
Side-effects to antibiotics in cystic fibrosis. I: ocular changes in relation to antibiotic administration and to severity of pulmonary involvement.
Topics: Adolescent; Anti-Bacterial Agents; Blindness; Child; Child, Preschool; Chloramphenicol; Clinical Tri | 1966 |
29 other studies available for chloramphenicol and Cystic Fibrosis
| Article | Year |
|---|---|
Antimicrobial susceptibility and synergy studies of Burkholderia cepacia complex isolated from patients with cystic fibrosis.
Topics: Anti-Bacterial Agents; Burkholderia cepacia complex; Burkholderia Infections; Cystic Fibrosis; Drug | 2007 |
Antibiotic resistance in Pseudomonas aeruginosa strains with increased mutation frequency due to inactivation of the DNA oxidative repair system.
Topics: Cystic Fibrosis; DNA Repair; Drug Resistance, Bacterial; Humans; Microbial Sensitivity Tests; Mutati | 2009 |
Comparative in vitro activities of meropenem in combination with colistin, levofloxacin, or chloramphenicol against Achromobacter xylosoxidans strains isolated from patients with cystic fibrosis.
Topics: Achromobacter denitrificans; Anti-Bacterial Agents; Chloramphenicol; Colistin; Cystic Fibrosis; Drug | 2020 |
Characterization of poxtA, a novel phenicol-oxazolidinone-tetracycline resistance gene from an MRSA of clinical origin.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Chloramphenicol; Computational Biology; Cystic Fibrosis; | 2018 |
50 Years Ago in The Journal of Pediatrics: Visual Disturbances in Cystic Fibrosis following Chloramphenicol Administration.
Topics: Anti-Bacterial Agents; Child; Chloramphenicol; Cystic Fibrosis; History, 20th Century; Humans; Optic | 2016 |
Lactic Acidosis with Chloramphenicol Treatment in a Child with Cystic Fibrosis.
Topics: Acidosis, Lactic; Adolescent; Burkholderia cepacia; Burkholderia Infections; Chloramphenicol; Cystic | 2017 |
Chloramphenicol for long-term therapy of cystic fibrosis.
Topics: Chloramphenicol; Cystic Fibrosis; Humans | 1963 |
OPTIC NEURITIS IN CYSTIC FIBROSIS OF THE PANCREAS. ROLE OF CHLORAMPHENICOL THERAPY.
Topics: Child; Chloramphenicol; Cystic Fibrosis; Diagnosis; Humans; Ophthalmoscopy; Optic Neuritis; Patholog | 1964 |
OPTIC ATROPHY INDUCED BY CHLORAMPHENICOL.
Topics: Adolescent; Anti-Bacterial Agents; Bronchiectasis; Child; Chloramphenicol; Cystic Fibrosis; Drug The | 1964 |
OPTIC ATROPHY IN CYSTIC FIBROSIS OF THE PANCREAS.
Topics: Child; Chloramphenicol; Cystic Fibrosis; Demyelinating Diseases; Drug Therapy; Humans; Optic Atrophy | 1965 |
LIPID PATTERNS OF ANTIBIOTIC RESISTANT AND SENSITIVE STRAINS OF STAPHYLOCOCCUS AUREUS ASSOCIATED WITH CYSTIC FIBROSIS OF THE PANCREAS.
Topics: Anti-Bacterial Agents; Bacteriological Techniques; Chloramphenicol; Chromatography; Cystic Fibrosis; | 1965 |
Chloramphenicol optic neuritis. Apparent protective effects of very high daily doses of pyridoxine and cyanocobalamin.
Topics: Child; Chloramphenicol; Cystic Fibrosis; Female; Humans; Optic Neuritis; Pyridoxine; Vitamin B 12 | 1967 |
Pseudomonas and other organisms in cystic fibrosis.
Topics: Child; Chloramphenicol; Cystic Fibrosis; Female; Haemophilus Infections; Haemophilus influenzae; Hum | 1982 |
Chloramphenicol optic neuropathy.
Topics: Adolescent; Child; Chloramphenicol; Cystic Fibrosis; Electroretinography; Evoked Potentials; Female; | 1980 |
MICs of rifampicin and chloramphenicol for mucoid Pseudomonas aeruginosa strains are lower when human lactoferrin is present.
Topics: Anti-Bacterial Agents; Chloramphenicol; Cystic Fibrosis; Drug Synergism; Humans; Lactoferrin; Microb | 1997 |
Degeneration of fasciculus gracilis in cystic fibrosis.
Topics: Adolescent; Autopsy; Child, Preschool; Chloramphenicol; Cystic Fibrosis; Humans; Nerve Degeneration; | 1977 |
Depression of erythropoiesis, physical growth, and hair growth by chloramphenicol in a three-year-old child with cystic fibrosis.
Topics: Anorexia; Child, Preschool; Chloramphenicol; Cystic Fibrosis; Depression, Chemical; Erythropoiesis; | 1977 |
The effect of exocrine pancreatic function on chloramphenicol pharmacokinetics in patients with cystic fibrosis.
Topics: Administration, Oral; Adolescent; Adult; Chloramphenicol; Cystic Fibrosis; Humans; Injections, Intra | 1988 |
Ocular findings in cystic fibrosis.
Topics: Adolescent; Adult; Child; Child, Preschool; Chloramphenicol; Color Vision Defects; Cystic Fibrosis; | 1987 |
Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.
Topics: Adolescent; Bronchopneumonia; Child; Child, Preschool; Chloramphenicol; Cloxacillin; Cystic Fibrosis | 1970 |
Discoloration of the teeth in a 24-year-old patient with cystic fibrosis of the pancreas not primarily associated with tetracycline therapy. Report of a case.
Topics: Adult; Bronchopneumonia; Chloramphenicol; Cystic Fibrosis; Erythromycin; Female; Humans; Kanamycin; | 1967 |
Sensitivity of Pseudomonas aeruginosa to normal serum and to polymyxin.
Topics: Animals; Blood; Blood Bactericidal Activity; Chloramphenicol; Chlortetracycline; Cystic Fibrosis; Da | 1969 |
An in vitro system for studying mucus secretion and other physiological activities in human intestinal mucosa.
Topics: Amphotericin B; Ampicillin; Autoradiography; Chloramphenicol; Culture Techniques; Cystic Fibrosis; G | 1970 |
[Bronchiectases secondary to cystic fibrosis in childhood].
Topics: Bronchiectasis; Carbenicillin; Child; Child, Preschool; Chloramphenicol; Cystic Fibrosis; Drainage; | 1972 |
Optic neuritis with prolonged use of chloramphenicol. Case report and relationship to fundus changes in cystic fibrosis.
Topics: Child; Chloramphenicol; Cystic Fibrosis; Female; Fundus Oculi; Humans; Optic Neuritis; Pseudomonas a | 1966 |
[Optic neuritis as a complication to treatment of cystic fibrosis with chloramphenicol].
Topics: Child; Child, Preschool; Chloramphenicol; Cystic Fibrosis; Female; Humans; Optic Atrophy; Optic Neur | 1972 |
Studies in cystic fibrosis. Report of 130 patients diagnosed under 3 months of age over a 20-year period.
Topics: Anemia; Body Weight; Chloramphenicol; Chlortetracycline; Cough; Cystic Fibrosis; Diabetes Mellitus, | 1970 |
[The course of mucoviscidosis. Experience at Giens Center].
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Bronchoscopy; Chloramphenicol; Cystic Fibrosis; Diab | 1969 |
Visual disturbances in cystic fibrosis following chloramphenicol administration.
Topics: Adolescent; Child; Chloramphenicol; Cystic Fibrosis; Eye Diseases; Female; Fundus Oculi; Humans; Mal | 1966 |